id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2017-0011-0006,EPA,EPA-HQ-OPP-2017-0011,Registration Reviews: Neonicotinoid Risk Assessments; Neonicotinoid Benefits Assessments,Notice,,2017-12-21T05:00:00Z,2017,12,,,2017-12-21T17:59:49Z,2017-27520,0,0,0900006482d48b80
EPA-HQ-OPP-2017-0011-0002,EPA,EPA-HQ-OPP-2017-0011,"Registration Reviews: Draft Human Health and/or Ecological Risk Assessments for Benfluralin, Bromuconazole, Carbaryl, Clodinafop-propargyl, Deltamethrin, Diflufenzopyr, Esfenvalerate, Lufenuron, and Mepiquat Chloride/Mepiquat Pentaborate",Notice,,2017-08-03T04:00:00Z,2017,8,,,2017-08-25T01:03:55Z,2017-16372,0,0,0900006482999952
EPA-HQ-OPP-2017-0011-0001,EPA,EPA-HQ-OPP-2017-0011,"Registration Reviews: Neonicotinoid Risk Assessments; Summary Response to Comments, and Updated Neonicotinoid Work Schedule",Notice,,2017-05-25T04:00:00Z,2017,5,,,2017-05-25T14:03:09Z,2017-10755,0,0,09000064826102e2